NCT06909279 Caregiver Training to Support Children With Social Communication Challenges
| NCT ID | NCT06909279 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Western University, Canada |
| Condition | Autism Spectrum Disorder |
| Study Type | INTERVENTIONAL |
| Enrollment | 72 participants |
| Start Date | 2025-05-06 |
| Primary Completion | 2026-04 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 72 participants in total. It began in 2025-05-06 with a primary completion date of 2026-04.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
"More Than Words® - The Hanen Program® for Parents of Autistic Children or Children Who May Benefit from Social Communication Support" is a family-focused intervention program delivered by a speech-language pathologist (SLP). The goal of More Than Words is to empower parents to be the main facilitator of their child's social communication development, which increases the child's opportunities to develop social communication skills in everyday situations. It is one of the programs offered to families who receive services from Ontario's Preschool Speech and Language program, although some regions are not able to offer it at all or are only able to offer a shortened version of the program. The Hanen Centre recently made updates to the More Than Words program to allow it to be delivered virtually (online) and to align with the latest evidence. Past research has found some evidence that the More Than Words program is effective, but knowledge is needed about the latest version of the program, including how effective it is when delivered online. It is important to understand who this program works best for and why. The purpose of the current study, called a pilot study, is to test a study plan that could be used in a future large study to answer these questions. In this pilot study, the investigators will test procedures for comparing the outcomes of families who receive the More Than Words program to families who have not yet received it. Additionally, procedures for understanding varying responses to treatment will be tested. The study aims to determine whether the methods used for recruiting families, delivering the program, and monitoring progress are practical and function as expected in preparation for the future large-scale study.
Eligibility Criteria
Inclusion criteria: 1. The child is under 48 months of age at the time of study enrolment. 2. The child has delays in social communication and play skills according to the clinical assessment of the child's community SLP. 3. The parent (or other primary caregiver) has a smart phone, tablet, or computer with webcam and internet access to attend the virtual MTW sessions and complete study measures 4. The parent is available to attend the 13-week virtual MTW program (which includes 9 online group sessions on Saturday mornings or Monday evenings). 5. The parent is comfortable communicating and filling out forms in English. Exclusion Criteria: Failure to meet the inclusion criteria outlined above.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06909279 clinical trial?
This trial is open to participants of all sexes, up to 47 Months, studying Autism Spectrum Disorder. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06909279 currently recruiting?
Yes, NCT06909279 is actively recruiting participants. Contact the research team at janis.oram@uwo.ca for enrollment information.
Where is the NCT06909279 trial being conducted?
This trial is being conducted at London, Canada.
Who is sponsoring the NCT06909279 clinical trial?
NCT06909279 is sponsored by Western University, Canada. The trial plans to enroll 72 participants.